ICUIICU Medical, Inc.
$160.40+22% 1Y
$160.40
$114.1352 weeks$187.34
The financials
ICU Medical, Inc. by the numbers
ICU Medical, Inc. (ICUI) reported revenue of $552M in Q2 2026 (quarter ended Jun 30, 2026), up 0.5% from the same quarter a year earlier. That came with a gross margin of 43% and net income of $19M (3.5% of revenue). For the full year FY2025, revenue was $2.23B (−6.3% year on year) and net income $732K. Its largest product in Q2 2026 was Infusion Consumables at $289M, 52% of the disclosed total, ahead of Infusion Systems at 34%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $552M | $549M | +0.5% |
| Gross profit | $235M | $208M | +13% |
| Operating income | $39M | $11M | +270% |
| Net income | $19M | $35M | −46% |
| Diluted EPS | $0.76 | $1.43 | −47% |
| Product | Revenue | Share |
|---|---|---|
| Infusion Consumables | $289M | 52% |
| Infusion Systems | $189M | 34% |
| Vital Care | $73M | 13% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $551.7M (+4.0%)
Infusion Systems grew +13% year on yearVital Care -32% year on year
Segment Latestquarter on quarteryear on year
- Infusion Consumables$289.3M$289.3Mquarter on quarter +4.0%year on year +5.9%+4.0%+5.9%
- Infusion Systems$189.0M$189.0Mquarter on quarter +5.2%year on year +13%+5.2%+13%
- Vital Care$73.4M$73.4Mquarter on quarter +1.5%year on year -32%+1.5%-32%
Medical Instruments & Supplies
Ranks #14 of 21 by RyuScore